Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Cancers
|
January 20, 2021
Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
Kate J Dixon, Jianming Wu, Bruce Walcheck
Frontiers in Immunology
|
August 9, 2021
Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation
Hemant K Mishra, Kate J Dixon, Nabendu Pore, et al.
Frontiers in Immunology
|
June 13, 2018
IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells
Alex M Abel, Aradhana A Tiwari, Zachary J Gerbec, et al.
Frontiers in Immunology
|
February 16, 2026
Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicity
Kate J Dixon, Robert Hullsiek, Sam Wang, et al.
Molecular Immunology
|
July 9, 2021
MyD88 is an essential regulator of NK cell-mediated clearance of MCMV infection
Kate J Dixon, Jason R Siebert, Dandan Wang, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2023
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
Kristin M Snyder, Kate J Dixon, Zachary Davis, et al.
Frontiers in Immunology
|
August 5, 2024
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
Kate J Dixon, Kristin M Snyder, Melissa Khaw, et al.
Journal for Immunotherapy of Cancer
|
July 25, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W Matson, Rob Hullsiek, Kate J Dixon, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W Matson, Rob H Hullsiek, Kate J Dixon, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Cancers
|
January 20, 2021
Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
Kate J Dixon, Jianming Wu, Bruce Walcheck
Frontiers in Immunology
|
August 9, 2021
Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation
Hemant K Mishra, Kate J Dixon, Nabendu Pore, et al.
Frontiers in Immunology
|
June 13, 2018
IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells
Alex M Abel, Aradhana A Tiwari, Zachary J Gerbec, et al.
Frontiers in Immunology
|
February 16, 2026
Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicity
Kate J Dixon, Robert Hullsiek, Sam Wang, et al.
Molecular Immunology
|
July 9, 2021
MyD88 is an essential regulator of NK cell-mediated clearance of MCMV infection
Kate J Dixon, Jason R Siebert, Dandan Wang, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2023
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
Kristin M Snyder, Kate J Dixon, Zachary Davis, et al.
Frontiers in Immunology
|
August 5, 2024
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
Kate J Dixon, Kristin M Snyder, Melissa Khaw, et al.
Journal for Immunotherapy of Cancer
|
July 25, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W Matson, Rob Hullsiek, Kate J Dixon, et al.
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W Matson, Rob H Hullsiek, Kate J Dixon, et al.
Page
of 1